Jaroszyński et al. demonstrated that lower serum levels of HSP27 in patients on HD are related to carotid atherosclerosis and oxidative stress, and they also revealed that HSP27 is independently associated with sudden cardiac death (SCD) in patients undergoing HD treatment. This evidence concerns the gene HSPB2 and sudden cardiac arrest.